✦ LIBER ✦

Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancer

✍ Scribed by D. Mack; J. Frick

Book ID: 119487796
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 401 KB
Volume: 45
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(99)80115-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose bacille Calmette-Guerin (BCG) t

Low-dose bacille Calmette-Guerin (BCG) therapy in superficial high-risk bladder cancer: a phase II study with the BCG strain Connaught Canada

✍ D. Mack; J. Frick 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Risk factors for positive findings in pa

Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR

✍ Anna Orsola; Lluís Cecchini; Carles X. Raventós; Enric Trilla; Jacques Planas; S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Analysis of progression and survival aft

Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancer

✍ Truls Gårdmark; Staffan Jahnson; Rolf Wahlquist; Hans Wijkström; Per-Uno Malmstr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Long-term follow-up of a randomized pros

Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guérin with a reduced dose of 27mg in superficial bladder cancer.: BJU Int 2002;89:671–680.

✍ J.A Martinez-Pineiro; N Flores; S Isorna; E Solsona; J.L Sebastián; C Pertusa; L 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 22 KB

The Impact of Intravesical Gemcitabine a

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

✍ Gontero, Paolo; Oderda, Marco; Mehnert, Anja; Gurioli, Alberto; Marson, Francesc 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 618 KB

Re: Final Results of an EORTC-GU Cancers

Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-Third Dose versus Full Dose and 1 Year versus 3 Years of Maintenance

✍ Wood, David P. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB